Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
D000433:1-Propanol; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001712:Biperiden / Q000494:pharmacology; D003510:Cyclohexanes; D003517:Cyclopentanes; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D008694:Methamphetamine / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D009046:Motor Neurons / Q000187:drug effects / Q000502:physiology*; D009069:Movement Disorders / Q000139:chemically induced; D010277:Parasympathomimetics / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors*; D013116:Spinal Cord / Q000187:drug effects / Q000502:physiology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014282:Trihexyphenidyl / Q000494:pharmacology*
D003510:Cyclohexanes; D003517:Cyclopentanes; D010277:Parasympathomimetics; D010880:Piperidines; D013566:Sympathomimetics; D001712:Biperiden; D008694:Methamphetamine; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D001285:Atropine; D012110:Reserpine; D000433:1-Propanol